Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Pigna, Eva ^a   Berardi, Emanuele ^a,b   Aulino, Paola ^a   Rizzuto, Emanuele ^a   Zampieri, Sandra ^c,d   Carraro, Ugo ^e   Kern, Helmut ^d   Merigliano, Stefano ^c   Gruppo, Mario ^c   Mericskay, Mathias ^f   Li, Zhenlin ^f   Rocchi, Marco ^g   Barone, Rosario ^h   Macaluso, Filippo ^h   Di Felice, Valentina ^h   Adamo, Sergio ^a   Coletti, Dario ^a,f   Moresi, Viviana ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF PADOVA   (Italy)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^e IRCCS SAN CAMILLO HOSPITAL   (Italy)

^f Groupe Enzymologie Moléculaire et Fonctionnelle   (France)

^g UNIVERSITY OF URBINO   (Italy)

^h UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; RAPAMYCIN; RIBONUCLEOTIDE;

ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL EXPERIMENT; AUTOPHAGOSOME; AUTOPHAGY; BAGG ALBINO MOUSE; CACHEXIA; CANCER TRANSPLANTATION; COLON TUMOR; CYTOLOGY; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; LYSOSOME; METABOLISM; MORTALITY; MOUSE; MUSCLE WEAKNESS; PATHOLOGY; PATHOPHYSIOLOGY; SKELETAL MUSCLE; SKELETAL MUSCLE CELL; SURVIVAL ANALYSIS; TUMOR CELL LINE;

AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; AUTOPHAGOSOMES; AUTOPHAGY; CACHEXIA; CELL LINE, TUMOR; COLONIC NEOPLASMS; FEMALE; HUMANS; LYSOSOMES; MICE; MICE, INBRED BALB C; MUSCLE FIBERS, SKELETAL; MUSCLE WEAKNESS; MUSCLE, SKELETAL; NEOPLASM TRANSPLANTATION; PHYSICAL CONDITIONING, ANIMAL; RIBONUCLEOTIDES; SIROLIMUS; SURVIVAL ANALYSIS;

EID: 84973402052     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26991     Document Type: Article

References (59)

1. Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359-E386 (2015).
2. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA Cancer J. Clin. 62, 10-29 (2012).
3. Irwin, M. L. et al. Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J. Clin. Oncol. 26, 3958-3964 (2008).
4. Meyerhardt, J. A. et al. Physical activity and survival after colorectal cancer diagnosis. J. Clin. Oncol. 24, 3527-3534 (2006).
5. Mark-Wahnefried, W. Cancer survival: time to get moving? Data accumulate suggesting a link between physical activity and cancer survival. J. Clin. Oncol. 24, 3517-3518 (2006).
6. Irwin, M. L. et al. Physical activity levels among breast cancer survivors. Med. Sci. Sports Exerc. 36, 1484-1491 (2004).
7. Montazeri, A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J. Exp. Clin. Cancer Res. 27, 32 (2008).
8. Evans, W. J. et al. Cachexia: a new definition. Clin. Nutr. 27, 793-799 (2008).
9. Fearon, K. et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 12, 489-495 (2011).
10. Thomas, D. R. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin. Nutr. 26, 389-399 (2007).
11. He, W. A. et al. NF-kappaB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J. Clin. Invest 123, 4821-4835 (2013).
12. Kumar, N. B. et al. Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment. Curr. Treat. Options. Oncol. 11, 107-117 (2010).
13. al-Majid, S. & McCarthy, D. O. Resistance exercise training attenuates wasting of the extensor digitorum longus muscle in mice bearing the colon-26 adenocarcinoma. Biol. Res. Nurs. 2, 155-166 (2001).
14. Egan, B. & Zierath, J. R. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab 17, 162-184 (2013).
15. Acharyya, S. et al. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell 8, 421-432 (2005).
16. Hawley, J. A. & Holloszy, J. O. Exercise: it's the real thing! Nutr. Rev. 67, 172-178 (2009).
17. Narkar, V. A. et al. AMPK and PPARdelta agonists are exercise mimetics. Cell 134, 405-415 (2008).
18. Mounier, R. et al. Antagonistic control of muscle cell size by AMPK and mTORC1. Cell Cycle 10, 2640-2646 (2011).
19. Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132-141 (2011).
20. Sanchez, A. M. et al. AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3 a and interaction with Ulk1. J. Cell Biochem. 113, 695-710 (2012).
21. Gwinn, D. M. et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226 (2008).
22. Zhao, J., Brault, J. J., Schild, A. & Goldberg, A. L. Coordinate activation of autophagy and the proteasome pathway by FoxO transcription factor. Autophagy. 4, 378-380 (2008).
23. Dobrowolny, G. et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 8, 425-436 (2008).
24. Mammucari, C. et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6, 458-471 (2007).
25. Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell 132, 27-42 (2008).
26. Spitali, P. et al. Autophagy is Impaired in the Tibialis Anterior of Dystrophin Null Mice. PLoS Curr. 5, (2013).
27. Masiero, E. et al. Autophagy is required to maintain muscle mass. Cell Metab 10, 507-515 (2009).
28. Choi, A. M., Ryter, S. W. & Levine, B. Autophagy in human health and disease. N. Engl. J. Med. 368, 1845-1846 (2013).
29. Aulino, P. et al. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC. Cancer 10, 363 (2010).
30. Sorrells, A. D. et al. Effects of environmental enrichment on the amyotrophic lateral sclerosis mouse model. Lab Anim 43, 182-190 (2009).
31. Glass, D. J. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat. Cell Biol. 5, 87-90 (2003).
32. Penna, F. et al. Autophagic degradation contributes to muscle wasting in cancer cachexia. Am. J. Pathol. 182, 1367-1378 (2013).
33. Lim, J. A., Li, L. & Raben, N. Pompe disease: from pathophysiology to therapy and back again. Front Aging Neurosci. 6, 177 (2014).
34. He, C. et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 481, 511-515 (2012).
35. Pauly, M. et al. AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm. Am. J. Pathol. 181, 583-592 (2012).
36. Grumati, P. et al. Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration. Nat. Med. 16, 1313-1320 (2010).
37. Shintani, T. & Klionsky, D. J. Autophagy in health and disease: a double-edged sword. Science 306, 990-995 (2004).
38. Loberg, R. D., Bradley, D. A., Tomlins, S. A., Chinnaiyan, A. M. & Pienta, K. J. The lethal phenotype of cancer: the molecular basis of death due to malignancy. CA Cancer J. Clin. 57, 225-241 (2007).
39. Blum, D. et al. Evolving classification systems for cancer cachexia: ready for clinical practice? Support. Care Cancer 18, 273-279 (2010).
40. Argiles, J. M., Busquets, S., Lopez-Soriano, F. J., Costelli, P. & Penna, F. Are there any benefits of exercise training in cancer cachexia? J. Cachexia. Sarcopenia. Muscle 3, 73-76 (2012).
41. Chang, V. T., Hwang, S. S., Feuerman, M. & Kasimis, B. S. Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer 88, 1175-1183 (2000).
42. Tanaka, Y. et al. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res. 50, 2290-2295 (1990).
43. Weyermann, P. et al. Orally available selective melanocortin-4 receptor antagonists stimulate food intake and reduce cancer-induced cachexia in mice. PLoS One 4, e4774 (2009).
44. Coletti, D. et al. Substrains of inbred mice differ in their physical activity as a behavior. Scientific World Journal. 2013, 237260 (2013).
45. Coletti, D. et al. Spontaneous Physical Activity Downregulates Pax7 in Cancer Cachexia. Stem Cells Int. 2016, 2016:6729268. doi: 10.1155/2016/6729268 (2016).
46. Wang, Y. & Pessin, J. E. Mechanisms for fiber-type specificity of skeletal muscle atrophy. Curr. Opin. Clin. Nutr. Metab Care 16, 243-250 (2013).
47. Sandri, M. et al. Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise. FEBS Lett. 373, 291-295 (1995).
48. Sandri, M. et al. Exercise induces myonuclear ubiquitination and apoptosis in dystrophin-deficient muscle of mice. J. Neuropathol. Exp. Neurol. 56, 45-57 (1997).
49. Ju, J. S., Varadhachary, A. S., Miller, S. E. & Weihl, C. C. Quantitation of "autophagic flux" in mature skeletal muscle. Autophagy. 6, 929-935 (2010).
50. Sandri, M., Coletto, L., Grumati, P. & Bonaldo, P. Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies. J. Cell Sci. 126, 5325-5333 (2013).
51. Masiero, E. & Sandri, M. Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles. Autophagy. 6, 307-309 (2010).
52. Lampe, A. K. & Bushby, K. M. Collagen VI related muscle disorders. J. Med. Genet. 42, 673-685 (2005).
53. De, P. C. et al. Autophagy as a new therapeutic target in Duchenne muscular dystrophy. Cell Death. Dis. 3, e418 (2012).
54. Grumati, P., Coletto, L., Sandri, M. & Bonaldo, P. Autophagy induction rescues muscular dystrophy. Autophagy. 7, 426-428 (2011).
55. Bueno Junior, C. R. et al. Combined effect of AMPK/PPAR agonists and exercise training in mdx mice functional performance. PLoS One 7, e45699 (2012).
56. Mousavi, Z., Dourandish, L., Rokni, H., Sadeghi, R. & Rasoul, Z. S. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer. Minerva Endocrinol. 39, 59-65 (2014).
57. Mackay, H. J. et al. Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer. Cancer 120, 603-610 (2014).
58. Pedersen, L. et al. Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution. Cell Metab 23, 554-562 (2016).
59. Zajac, M. S. et al. Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice. Hippocampus 20, 621-636 (2010).